LA-MCA 2024 Program

7th Annual Meeting

3

EVEN

A

serum

help target and prevent visible discoloration. This is designed to be a foundation in your patients’ daily regimen.

EVEN & CORRECT DARK SPOT CREAM

A heavy-duty, targeted, fast-acting spot treatment booster that minimizes the look of dark spots. For use as needed.

EVEN &

PADS

Alcohol-free brightening pads exfoliate for visibly bright skin. They prep the skin for absorption of treatment products.

FEMALE, ASIAN, AGE 69, FITZPATRICK SKIN TYPE III. Unretouched photos, taken in standard lighting of subject at baseline and week 12 after use of Even &

SCAN CODE FOR ADDITIONAL INFORMATION ABOUT THIS NEW COLLECTION

CAUTION: Women should not use Even & Correct Dark Spot Cream if they are pregnant, lactating, or planning to become pregnant.

Sunburn alert: Even & Correct Brightening Treatment Pads and Even & Correct Dark Spot Cream contain an alpha-hydroxy acid (AHA) that may increase your skin’s sensitivity to sunburn. Use a sunscreen and limit sun exposure while using these products and for a week following discontinuation.

Use a sunscreen with an SPF of 30 or higher during any sun exposure when using Even & Correct Advanced Brightening Treatment.

Most SkinMedica® products are intended to meet the FDA’s definition of a cosmetic product, an article applied to the human body to cleanse, beautify, promote attractiveness, and alter appearances. These SkinMedica® products are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition. These products have not been approved by the FDA, and the statements here have not been evaluated by the FDA.

© 2023

LA-MCA 2024 EXPERT FACULTY

Esteemed Planning Committee and Scientific Advisors Speakers

Shino Bay Aguilera, DO

Gal Aharonov, MD

Demetri Arnaoutakis, MD

Yara Attalla, RPN

Sheila Barbarino, MD

Daniel Barrett, MD

Julie Bass Kaplan, FNP

Charles Boyd, MD

Priya Chadha, MD

Shawna Chrisman, ACNP

Joel Cohen, MD

Shanna Concepcion, RN

Natasha Cook, MD

Anusha Dahanyake, NP

Julie Davis, JD MHA

Josh DeBlasio

Karan Dhir, MD

John Diaz, MD

Kay Durairaj, MD

Lisa Espinoza, MD

Amy Faircloth, RN

Rachel Fidino, DNP

Zena Gabriel, MD

Charles Galanis, MD

Conor Gallagher

Richard Gentile, MD

Dr. Giulio Giammarioli

Robert Goldberg, MD

Dan Gould, MD

Lisa Grunebaum, MD

Natalia Guzman, FNP

Milad Haydarian

Brian Hayes

Annie Hockey

Amanda Holden, MD

Jennifer Hollander, FNP

Julie Horne, RN

Raffi Hovsepian, MD

Richard Jin, MD

Jeffrey Joseph, MD

John Joseph, MD

Kian Karimi, MD

Saami Khalifian, MD

Artem Kutikov, PhD

Trevor Larsen, RN

Wendy Lee, MD

Stefanie Lenard

David Lieberman, MD

Joelle Lieman, MD

Christopher Lo, MD

Amy Lynn, RN

Dr. Sara Mahdavi, PhD

Marc Mani, MD

Alec McCarthy, MD

Kara McClanahan

Jennifer Murdock, MD

Nima Naghshineh, MD

Mohsen Naraghi, MD

Michael Newman, MD

Joseph Niamtu, III, DMD

Nicholas Nikolov, MD

Sachin Parikh, MD

Laurence Rifkin, DDS

Alexander Rivkin, MD

Estee Rodriguez

Mark Rodriguez

Kelsey Roelofs, MD

Jared Rohrer

David Saadat, MD

Kevin Sadati, DO

David Samimi, MD

Adam Scheiner, MD

Anil Shah, MD

Ava Shamban, MD

Megan Smith

Sherly Soleiman, MD

Steven Sorr, NMD

Sharon Stewart, PAC

Jonathan Sykes, MD

TJ Tsay, MD

John Vartanian, MD

Nate Villaneuva, MD

Lee Walker, BDS

Hermine Warren, DNP

Steven F. Weiner, MD

Julie Woodward, MD

Steven Yoelin, MD

Francine Young, RN

Sandy Zhang-Nunes, MD

Hedyeh Ziai, MD

Josh DeBlasio Marketing/Business

Joel Cohen, MD Dermatology

John Diaz, MD Plastic Surgery

John Joseph, MD Facial Plastic Surgery

Amy Lynn, RN Aesthetic Nursing

Kelsey Roelofs, MD Oculoplastic Surgery

Kian Karimi, MD Course Chairman

Angela O’Mara Program Director

Giles Raine Director Industry Partnerships

SEE THE EFFECT FEEL THE DIFFERENCE

First and original PLLA biostimulator since 1999.1,2

25 YEARS LATER, SCULPTRA® HAS AN UNMATCHED PROVEN SAFETY PROFILE AND EFFICACY.3,4

REFERENCES: 1. Bergeret-Galley C. Comparison of Resorbable Soft Tissue Fillers. Aesthetic Surg J. 2004; 24:33-46. 2. Data on file. MA-46589. Galderma Laboratories, L.P., 2021. 3. Sculptra. Instructions for Use. Galderma Laboratories, L.P., 2023. 4. Narins RS, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol. 2010 Mar;62(3):448 -462.

Important Safety Information

Indication: Sculptra® (injectable poly-L-lactic acid (PLLA-SCA)) is indicated for use in people with healthy immune systems for the correction of shallow to deep nasolabial fold contour deficiencies, fine lines and wrinkles in the cheek region, and other facial wrinkles.

Sculptra should not be used by people that are allergic to any ingredient of the product or have a history of keloid formation or hypertrophic scarring. Safety has not been established in patients who are pregnant, lactating, breastfeeding, or under 18 years of age.

Sculptra has unique injection requirements and should only be used by a trained healthcare practitioner. Contour deficiencies should not be overcorrected because they are expected to gradually improve after treatment. Sculptra should not be injected into the blood vessels as it may cause vascular occlusion, infarction or embolic phenomena. Use at the site of skin sores, cysts, pimples, rashes, hives or infection should be postponed until healing is complete. Sculptra should not be injected into the red area (vermillion) of the lip or in the peri-orbital area.

The most common side effects after initial treatment include injection site swelling, tenderness, redness, pain, bruising, bleeding, itching and lumps. Other side effects may include small lumps under the skin that are sometimes noticeable when pressing on the treated area. Larger lumps, some with delayed onset with or without inflammation or skin discoloration, have also been reported.

Sculptra is available only through a licensed practitioner. Complete Instructions for Use are available at www.SculptraUSA.com/IFU.

© 2024 Galderma Laboratories, L.P.

WEDNESDAY, MARCH 20, 2024 MAIN BALLROOM

5:00 pm - 8 pm Early Registration Opens

Day 1 - Track 1 in Main Ballrooms

Thursday March 21, 2024

7:30 a.m

9:00 - 9:15

9:15 - 11:00

9:15 - 9:30

9:30 - 9:45

9:45 - 10:00

REGISTRATION & EXHIBITS OPEN!

Welcome to LA-MCA 2024!

Kian Karimi, MD – Course Chairman

Main Ballroom Sessions

FOREHEAD & TEMPLE: Surgical & Non-Surgical Approaches

Moderator: Lisa Grunebaum, MD

Anatomical Basis of Forehead and Temple Injections – Jonathan Sykes, MD

Fillers to Forehead/Temple – Lisa Grunebaum, MD

Hairline Lowering With and Without Browlifting – Gal Aharanov, MD

10:00 - 10:15 Is 6 Month Duration the New Bar for Toxin Injections – John Joseph, MD

10:15 - 10:30

10:30 - 10:45

What Works Non-Surgically to Lift the Brows – Sheila Barbarino, MD

Framing The Upper Face – Temple, Brow & Zygoma Using FIllers – Anusha Dahanyake, NP

10:45 - 11:00 PANEL With Live Q&A – Gal Aharanov, MD, Sheila Barbarino, MD, Anusha Dahanyake, NP, Lisa Grunebaum, MD, John Joseph, MD, Jonathan Sykes, MD

11:00 - 12:30

HOT TOPICS AND CONTROVERSIES IN AESTHETICS - HEAR IT FROM THE EXPERTS

11:00 - 11:45 PRF, PRP sessions – Sorting the Data & Practical Applications

11:45 - 12:30

12:30 - 1:30

1:30 - 3:15

1:30 - 1:45

1:45 - 2:00

2:00 - 2:15

2:15 - 2:30

2:30 - 2:45

2:45 - 3:00

3:00 - 3:15

3:15 - 3:45

3:45 - 6:30

3:45 - 4:30

4:30 - 5:15

5:15 - 6:30

6:30 - 8:00

– Shanna Concepcion, RN, Kian Karimi, MD, Richard Jin, MD, Francine Young, RN

Hyaluronidase Protocols for Management of Vascular Occlusion & Ocular Compromise: Case Presentations, Protocols, Debate

Moderator: Steven Yoelin, MD

Presentations follows by Panel and Live Q&A

– Julie Bass Kaplan, FNP, Saami Khalifian, MD, Kelsey Roelofs, MD, Julie Woodward, MD, Steve Yoelin, MD, Sandy Zhang-Nunes, MD

Lunch Break with Exhibitors

EYES & MID-FACE: Surgical & Non-Surgical Approaches

Moderator: Kelsey Roelofs, MD

Eye & Mid-Face Fillers: Considerations & Techniques – Priya Chadha, MD

Minimally Invasive Options To Rejuvenate The Eye & Midface – John Vartanian, MD

Surgical Rejuvenation Eyes & Mid-Face – Kelsey Roelofs, MD

Neurotoxin Techniques: Eyes & Mid-Face – Julie Bass Kaplan, FNP

Laser Treatment of Eyelid Festoons and Malar Mounds – Adam Scheiner, MD

An Off-the-Shelf Solution for Body Contouring and Volume Restoration – Nima Naghshineh, MD

PANEL With Live Q&A – Julie Bass Kaplan, FNP, Priya Chadha, MD, Nima Naghshineh, MD, Kelsey Roelofs, MD, Adam Scheiner, MD, John Vartanian, MD

Coffee Break with Exhibits

LIVE Demos – Regenerative Aesthetics – Highlights From The Industry – Non CME

Moderator: Kian Karimi, MD

Leading Regenerative Therapies: Creating a Paradigm Shift in Aesthetic Medicine – Steven Weiner, MD, Richard Jin, MD, TJ Tsay, MD

Regenerative Aesthetics With Radiesse Presentation – Kay Durairaj, MD

Galderma GAIN Live Demonstration – Priya Chadha, MD, Natalia Guzman, FNP, Julie Horne, RN, Kian Karimi, MD, Amy Lynn, RN

Welcome and Cocktail Reception! – Sponsored by Galderma. Celebrating 25 Years of Sculptra

www.cosmeticacademymeeting.org

Day 2 - Track 1 in Main Ballroom

Friday March 22, 2024 Main Ballroom Sessions

7:30 - 8:00

8:00 - 10:00

8:00 - 8:15

8:15 - 8:30

8:30 - 8:45

8:45 - 9:00

9:00 - 9:15

9:15 - 10:00

10:00 - 10:30

10:30 - 12:00

10:30 - 10:45

10:45 - 11:00

11:00 - 11:15

11:15 - 11:30

Breakfast with Exhibitors

BIOSTIMULATORY AESTHETICS

Moderator: Lisa Espinoza, MD

Bio-Stimulators: Current Applications – Natalia Guzman, FNP

Vertical Vectoring and Facial Balancing – Kay Durairaj, MD

Non-Surgical BBL’s with PLLA and How to Add Benefit to Your Practice – Raffi Hovsepian, MD

Autologous Blood Platelet Therapies as a BioFiller (PRF and albumin-PRF) – Kian Karimi, MD

Combination Biostimulators With HA - When to Use Which? – Lisa Espinoza, MD

PANEL With Live Q&A – Kay Durairaj, MD, Lisa Espinoza, MD, Natalia Guzman, FNP, Raffi Hovsepian, MD, Kian Karimi, MD

Break With Exhibitors

LIPS, CHIN, and JAWLINE: Surgical and Non-Surgical Approaches

Moderator: Joseph Niamtu, III, DMD

Update on Lips – Julie Woodward, MD

The Evolution of Lip & Perioral Augmentation: Current Trends & Future Direction – Lisa Espinoza, MD

Considerations of Facial Proportions and Aging Structural Changes To Deliver Harmonious Results – Laurence Rifkin, DDS

Chin Augmentation with Implants, Genioplasty, and Fillers – Joseph Niamtu, III, DMD

11:30 - 11:45 Energy Based Treatments For Jawline/Submentum – Demetri Arnaoutakis, MD

11:45 - 12:00

ReJAWvenation Technique – Steve F. Weiner, MD

12:00 - 12:30 PANEL With Live Q&A – Demetri Arnaoutakis, MD, Lisa Espinoza, MD, Joseph Niamtu, III, DMD, Laurence Rifkin, DDS, Steve F. Weiner, MD, Julie Woodward, MD

12:30 - 1:30

1:30 - 1:45

1:45 - 2:00

2:00 -5:30

2:00 - 2:30

2:30 - 3:45

3:45 - 4:30

Lunch with Exhibitors

Non-Surgical Approach to Difficult Lower Eyelids: A Multi-Modality Approach – Charles Boyd, MD

Under Eye Fillers: An Anatomic Guide to Proper Filling and Monitoring Changes Over Time – Jennifer Hollander, FNP

Leading Aesthetic Techniques – Live Demos – Non-CME

Moderator: Kian Karimi, MD

SPECIAL LECTURE – Psychology of Aesthetics – Jonathan Sykes, MD – Non-CME

Allergan: Skinvive by Juvederm Product Theater and Live Demonstration – Saami Khalifian, MD, Trevor Larsen, RN

Cellsound Demo Live – From Theory to Practice: Integrating Cellular Sound Therapy into Clinical Practice – Experience a live CellSound body contouring demonstration utilizing Electrosonic Resonance with immediate, transformative results.

Introduction and Q&A: Kian Karimi, MD –Moderator: Nicholas Nikolov, M.D., F.A.C.S.

Demonstration: Estee Rodriguez, VP of Clinical

4:30 - 5:30

LIVE DEMO: Pioneering Regenerative Aesthetics with ezGEL Bio-Stimulator

Join Kian Karimi, MD, FACS, Shanna Concepcion, RN, CANS, Dr. Sara Mahdavi, PhD, for an exclusive Live Demonstration on ezGEL. Discover the potential of this 100% Autologous and Bio-Stimulating Gel in Aesthetic Medicine. Gain valuable insights and practical skills for incorporating ezGEL into your practice, understanding its key role in addressing the growing demand for natural and authentic aesthetic solutions and results.

5:30 - 7:00

Innovations in Aesthetics Reception – Sponsored by CosmoFrance

7:30 PM Medical Faculty Dinner – Allergan Aesthetics

Day 2 - Track 2 Surgical Track - II Posto

Friday March 22, 2024

7:30 - 8:00

8:00 - 10:00

8:00 - 8:15

8:15 - 8:30

Breakfast with Exhibitors

Moderator: Kelsey Roelofs MD

Surgical Track - II Posto

SURGERY OF THE FOREHEAD, BROWS, TEMPORAL & PERIORBITAL REGIONS

How To Avoid and Fix Common Blepharoplasty Complications – Jennifer Murdock, MD

Blepharoplasty Considerations in the East Asian Eyelid – Robert Goldberg, MD

8:30 - 8:45 Laser Blepharoplasty – Julie Woodward, MD

8:45 - 9:00

Cosmetic Ptosis Surgery – Christopher Lo, MD

9:00 - 9:15 Lower Blepharoplasty Pearls For Transposition – Kelsey Roelofs, MD

9:15 - 9:30

Ocular Aesthetics: Bold Techniques: Are They Safe? – Wendy Lee, MD

9:30 - 10:00 PANEL With Live Q&A – Robert Goldberg, MD, Wendy Lee, MD, Christopher Lo, MD, Jennifer Murdock, MD, Kelsey Roelofs, MD, Julie Woodward, MD

10:00 - 10:30

10:30 - 12:00

Break With Exhibitors

ADVANCES IN SURGICAL FACIAL REJUVENATION

Moderator: Jonathan Sykes, MD

10:30 - 10:45 7 Steps To Achieving The Best Surgical Neckline – Sachin Parikh, MD

10:45 - 11:00

11:00 - 11:15

11:15 - 11:30

Anterior Belly of the Digastric Plication for Submental Contouring – Anil Shah, MD

Facelift Complications – David Lieberman, MD

Demystifying the Deep Plane Face Lift: Anatomy and Biomechanics – Jonathan Sykes, MD

11:30 - 11:45 PANEL With Live Q&A – David Lieberman, MD, Sachin Parikh, MD, Anil Shah, MD, Jonathan Sykes, MD

11:45 - 12:45

11:45 - 12:00

12:00 - 12:15

12:15 - 12:30

SURGERY OF THE FACE, LIPS & JAW

Moderator: Richard Gentile, MD

TESLA Facelifting – Combining Energy Devices with Rhytidectomy – Richard Gentile, MD

3D Custom Implants vs Prefabricated Implants – Karan Dhir, MD

Tips to Reduce Revision Surgery in Facelifts – Joseph Niamtu, III, DMD

12:30 - 12:45 PANEL With Live Q&A – Karan Dhir, MD, Richard Gentile, MD, Joseph Niamtu, III, DMD

12:45 - 1:45

1:45 - 3:00

1:45 - 2:00

2:00 - 2:15

2:15 - 2:30

2:30 - 3:00

3:00 - 5:00

3:00 - 3:15

3:15 - 3:30

3:30 - 3:45

3:45 - 4:00

4:00 - 4:15

4:15 - 5:00

Lunch with Exhibitors

COMBINED SURGICAL & NON-SURGICAL FACIAL TECHNIQUES (VIDEO DEMONSTRATIONS FROM OUR GLOBAL KOLS)

Moderator: Julie Woodward, MD

Full Face Layering With Multiple Modalities – Priya Chadha, MD

Correction of Post Rhinoplasty Imperfections with Non-Surgical Methods – Dr. Giulio Giammarioli

Managing Blepharoplasty Complications – Julie Woodward, MD

VIDEO TECHNIQUES OF FILLER INJECTIONS FROM – Priya Chadha, MD, Dr. Giulio Giammarioli, Julie Woodward, MD

SURGERY OF THE BREAST & BODY

Moderator: John Diaz, MD

Multimodal Treatment of the Aging Breast, The “LIFE” Procedure – Dan Gould, MD

Breast Revision: An Algorithm for Successful Outcomes – John Diaz, MD

Optimizing Outcomes in Liposculpting Through The Atlas Approach – Nate Villanueva, MD

Not a Mini, Not a Full: The Hybrid Tummy Tuck Approach – Charles Galanis, MD

Intra-Operative Use of PLLA in Conjunction with Small Volume Fat Transfer BBL’s to Achieve Optimal Results – Raffi Hovsepian, MD

PANEL With Live Q&A – John Diaz, MD, Charles Galanis, MD, Dan Gould, MD, Raffi Hovsepian, MD, Nate Villanueva, MD www.cosmeticacademymeeting.org

Day 2 - Track 3 Practice Marketing & Business Sessions

Friday March 22, 2024 Burton Room

7:30 - 8:00

8:00 - 10:00

8:00 - 10:00

8:00 - 8:20

8:20 - 8:40

8:40 - 9:00

9:00 - 9:20

9:20 - 9:40

9:40 - 10:00

10:00 - 10:20

10:20 - 10:40

10:40 - 11:15

11:15 - 12:30

12:30 - 1:30

1:30 - 1:45

1:45 - 2:05

2:05 - 2:25

2:25 - 2:45

2:45 - 3:05

3:05 - 3:20

3:20 - 3:40

3:40 - 4:00

4:00 - 5:00

Breakfast with Exhibitors in Main Exhibit Area

THE BUSINESS OF AESTHETIC MEDICINE - Practice Marketing & Business Sessions

Moderator: Josh DeBlasio

PEOPLE POWER! How To Equip Your Practice With a Winning Team & How To Be The BOSS and How To Lead That Team!

Recruitment: Where do I go to find the best people? – Kara McClanahan

Cultural Alignment: Attracting Talent That Fits Your DNA – Stefanie Lenard

Top 10 Biggest Mistakes To Avoid When Building Your Dream Team – Josh DeBlasio

Effective Compensations Strategies To Drive Performance and Enhance Patient Outcomes – Julie Davis, JD-MHA

Build Your Elite Team: A Modern Process For Consistently Hiring Exceptional People – Brian Hayes

Break With Exhibitors

In-Office Communication: How Much Is Not Enough/Too Much? – Kara McClanahan

Nurturing a Growth Mindset: Cultivating a Culture of Learning – Stefanie Lenard

PANEL: Staffing Challenges In A Post COVID World

Panel: Julie Davis, JD-MHA, Josh DeBlasio, Brian Hayes, Stefanie Lenard, Kara McClanahan

PANEL: Leading From The TOP: Business Owners Share Best Leadership Practices

Amy Faircloth, RN, Joelle Lieman, MD, Amy Lynn, RN, Hermine Warren, DNP

Lunch with Exhibitors

Aesthetics Mastery: Be Authentic – Milad Haydarian

AI: Will It Replace Our Marketing Team? – Kay Durairaj, MD

SEO and Google: Cracking The Code – Jared Rohrer

Post Aesthetic Conference: New Information, New Technology, Now What? – Hermine Warren, DNP

Reviews: Who Monitors? How Do We Handle The Bad Ones and How Do We Get More Good Ones? – Daniel Barrett, MD

Break With Exhibitors

Truth in Advertising: Non-Negotiables When It Comes To Before-and-After Photos – Jonathan Sykes, MD

How To Buy Ads On Social Media and How To Measure Their Success – Jared Rohrer

PANEL: Lessons Learned: The Biggest Marketing Mistakes To Avoid In Your Practice

Panel: Daniel Barrett, MD, Julie Davis, JD MHA, Kay Durairaj, MD, Jared Rohrer

www.cosmeticacademymeeting.org

Day 2 - Track 5

Friday March 22, 2024 Pavilion/Linden

SPONSORED WORKSHOPS

Palm Room

Friday

8:00 - 8:30 am

Friday 8:00 - 8:30 am

Friday

8:40 - 9:10 am

Friday 9:20 - 9:50 am

Friday 12:30 - 1:30 pm

Friday 2:00 - 3:00 pm

Discover The Power Of Platelet Derived Exosomes With Plated™ Skin Science

Steven F. Weiner, MD

Pavilion

CELLSOUND Introduces

Electrosonic Resonance: The Future of Regenerative Energy-Based Aesthetics

Mark Rodriguez, CEO, Co-Founder & Scientist

Pavilion

Just the Facts, Ma’am: All You Need to Know About DAXXIFY®

Ava Shamban, MD & Conor Gallagher, PhD, CSO

Pavilion

Unveiling the Future: Elevate Your Aesthetics with Sylfirm

X Dual Wave RF Micro Needling and Exosome Synergy

Saami Khalifian, MD & Francine Young, RN

Linden Room

Get Your lunch and Get the TEA on BOTOX Cosmetic

Julie Bass Kaplan, FNP

Linden Room

The Consultation Palette: Blending Artistry with Anatomy for Lower Face Aesthetic Enhancement

Dr. David Saadat & Nurse Yara, RPN

www.cosmeticacademymeeting.org

Fast. Lasts. And the Look.

Optimize patients’ results with the only neuromodulator formulated with Peptide Exchange Technology ™4-8

*Onset as early as day 1, typically within 2 days. Based on pooled patient diary data from SAKURA 1 and SAKURA 2.1,2,4 At least 50% of patients in SAKURA 1 and SAKURA 2 had none or mild frown lines for 24 weeks (6 months) and 23.9 weeks (6 months) or longer, respectively, per both investigator’s and patient’s assessments.9 64% of patients achieved an improvement in the appearance of skin texture at week 2 from a post hoc analysis of a phase 2 study with 60 patients.3

INDICATION

DAXXIFY® (daxibotulinumtoxinA-lanm) injection is an acetylcholine release inhibitor and neuromuscular blocking agent indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.

WARNING: DISTANT SPREAD OF TOXIN EFFECT

The effects of DAXXIFY® and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death.

DAXXIFY® is not approved for the treatment of spasticity or any conditions other than glabellar lines.

IMPORTANT SAFETY INFORMATION

Contraindications DAXXIFY® contraindications include hypersensitivity to any botulinum toxin preparation or any of the components in the formulation and infection at the injection site(s). Warnings and Precautions Please refer to Boxed Warning for Distant Spread of Toxin Effect. The potency Units of DAXXIFY® are not interchangeable with other preparations of

other botulinum toxin products. Recommended dose and frequency of administration should not be exceeded. Patients should seek immediate medical attention if respiratory, speech or swallowing difficulties occur. Use caution when administering to patients with pre-existing cardiovascular disease. Concomitant neuromuscular disorders may exacerbate clinical effects of treatment. Adverse Reactions The most commonly observed adverse reactions (≥1%) were headache (6%), eyelid ptosis (2%) and facial paresis (1%). Drug Interactions Co-administration of DAXXIFY® and aminoglycoside antibiotics, anticholinergic agents or any other agents interfering with neuromuscular transmission or muscle relaxants should only be performed with caution as the effect of DAXXIFY may be potentiated. The effect of administering different botulinum neurotoxins during course of treatment with DAXXIFY® is unknown. Use in Specific Populations DAXXIFY® is not recommended for use in children or pregnant women. Please see DAXXIFY® full Prescribing Information, including Boxed Warning and Medication Guide, at RevanceAesthetics.com. DAXI-001720.2

REFERENCES

1. Data on File. D220801001. Newark, CA: Revance Therapeutics, Inc; 2021. 2. Bertucci V, Solish N, KaufmanJanette J, et al. DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2). J Am Acad Dermatol. 2020;82(4):838-845. 3. Data on File. D231201010. Newark, CA: Revance Therapeutics, Inc; 2023. 4. DAXXIFY Prescribing Information. Revance Therapeutics, Inc; 2022. 5. Botox® Cosmetic. Prescribing Information. Allergan Inc; 2020. 6. Xeomin® Prescribing Information. Merz Pharmaceuticals GmbH; 2021. 7. Dysport®. Prescribing Information. Ipsen Biopharm Ltd; 2023. 8. Jeuveau® Prescribing Information. Evolus, Inc; 2020. 9. Carruthers JD, Fagien S, Joseph JH, et al. DaxibotulinumtoxinA for Injection for the treatment of glabellar lines: results from each of two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2). Plast Reconstr Surg. 2020;145(1):45-58.

©2024 REVANCE AESTHETICS. DAXXIFY, Revance Therapeutics, and the Revance logo are registered trademarks of Revance Therapeutics, Inc. All other trademarks are the property of their respective owners. DX00407 DAXI-00774

Day 3 - Track 1 in Main Ballroom

Saturday

March 23, 2024 Main Ballroom

7:30 - 8:00

8:00 - 10:00

8:00 - 8:30

8:30 - 8:45

8:45 - 9:00

9:00 - 9:15

9:15 - 9:35

9:35 - 9:50

9:50 - 10:00

10:00 -10:30

10:30 - 12:30

10:30 - 10:45

10:45 - 11:00

11:00 - 11:15

11:15 - 11:30

11:30 - 11:45

11:45 - 12:00

12:00 - 12:15

Breakfast with Exhibitors

Regenerative Aesthetics, Wellness, Sexual Wellness, and Longevity

Moderator: Kian Karimi, MD

My Personal Anti Aging Prescription – Natasha Cook, MD

Sexual Wellness/Treatments – Joelle Lieman, MD

Hormones and Wellness/Longevity – Steven Sorr, NMD

Electromagnetic Resonance in Aesthetics – Kian Karimi, MD

Dermatonutrigenomics - Nourishing Skin According to Genes – Dr. Sara Mahdavi, PhD

Latest Studies On Platelet Derived Exosomes – Lisa Espinoza, MD

Panel With Live Q&A – Natasha Cook, MD, Lisa Espinoza, MD, Kian Karimi, MD, Dr. Sara Mahdavi, PhD, Joelle Lieman, MD, Steven Sorr, NMD

Break with Exhibitors

Fillers & Injectables - Preventing and Managing Complications

Moderator: Sandy Zhang-Nunes, MD

Data on Reversal of Fillers – Sandy Zhang-Nunes, MD

Art of Reversal – Amy Lynn, RN

Treatment of Hyaluronic Acid Filler Related Periocular Edema – Jeffrey Joseph, MD

PDO Threads Complications - Prevention and Management – Kian Karimi, MD

Ultrasound Guided Management of Vascular Occlusions - New Data Presented – Steven F. Weiner, MD

Cannulating The Facial Artery for Vascular Occlusion – Steve Yoelin, MD

Non-Surgical Rhinoplasty Complications – Dr. Giulio Giammarioli

12:15 - 12:30 PANEL with Live Q&A – Dr. Giulio Giammarioli, Jeffrey Joseph, MD, Kian Karimi, MD, Amy Lynn, RN, Steven F. Weiner, MD, Steve Yoelin, MD, Sandy Zhang-Nunes, MD

12:30 - 1:30

1:30 - 3:00

3:00 - 3:30

3:30 - 4:30

4:30 - 5:30

4:30 - 4:45

4:45 - 5:00

5:00 - 5:15

5:15 - 5:30

6:00 - 8:30

Lunch with Exhibitors

Special Keynote Session: Aesthetic Filler Summit

Making Sense of ALL Fillers On The Market. Hear It From The Formulators & The Experts

Moderator: John Joseph, MD

Corporate and Clinician based discussions on New and Emerging Evidence-based Science and Clinical Applications of Current and Future Fillers in the Marketplace

Medical Faculty Speakers: John Joseph, MD, Alexander Rivkin, MD, Lee Walker, BDS, Steven F. WeIner, MD, Sandy Zhang-Nunes, MD

Scientific Industry Research Speakers: Conor Gallagher, PhD, Artem Kutikov, PhD, Alec McCarthy, MD

Break with Exhibitors

Shino Bay Aguilera, DO – Keynote Presentation

Don’t Fake Young - The Art of Living Youthfully

CONTROVERSIES & DEBATES

Moderator: Kian Karimi, MD

Scar Tissue From Injectables: Is It Real and What Are The Implications? The Pros and Cons of Fillers/Biostimulators – Marc Mani, MD & David Saadat, MD

Scar Tissue and Tissue Loss from Energy Based Devices - Is It Real and What Are The Implications? – Demetri Arnaoutakis, MD & Joel Cohen, MD

Non-Surgical Rhinoplasty Procedures: Should We Be Doing Them and Best Practices – Dr. Giulio Giammarioli & John Vartanian, MD

Q&A From Audience

Join the Party! - LA-MCA 7th Annual Celebration Party And Awards Ceremony – Pavilion

Moulin Rouge Theme Party! Co-Sponsor Benev – Ethan Min, BENEV CEO, Shino Bay Aguilera, DO COSTUME CONTEST WITH GRAND PRIZE!

www.cosmeticacademymeeting.org

Hosted by:

Kian Karimi MD, FACS, and Shanna Concepcion RN, CANS

Friday, March 22 4:30 PM – 5:30 PM Main Stage

Hosted by: Shanna Concepcion RN, CANS

Saturday, March 23 11:30 AM – 12:30 PM Beechwood Room

Day 3 - Track 5

Saturday

March 23, 2024 Beechwood

SPONSORED WORKSHOPS

Beechwood Room

Saturday 11:30 am - 12:30 pm

I’ll Show You How - Unlocking Aesthetic Possibilities with Combination Therapies

Shanna Concepcion, RN, CANS

An exclusive and limited-seat workshop where you will discover the power of combining various aesthetic treatments to achieve outstanding results. Shanna will share her deep expertise and practical tips, guiding you through the nuances of integrating techniques such as EZGEL Blood concentrate, and PDO Threads.. This is a unique opportunity to learn from one of the top injectors in the country and elevate your practice with cutting-edge combination therapies. Don’t miss this chance to enhance your skills and knowledge in an intimate, interactive setting.

www.cosmeticacademymeeting.org

TABLE #16 X

The world’s FIRST & ONLY Pulsed Wave & Continuous Wave RF Microneedling Device

Exosome the next small thing... Nanoparticles offering a new future

We’re Redefining Sutures

U.S FDA 510K Pre-loaded PDO Threads

Day 3 - Track 2 Surgical Track - II Posto

Saturday March 23, 2024

7:30 - 8:00

8:00 - 10:00

8:00 - 8:15

Breakfast with Exhibitors

Controversies in Cosmetic Surgery (and non-surgery)

Moderator: Marc Mani, MD

Can Fillers Actually Lift? – Sherly Soleiman, MD

8:15 - 8:30 Non-Surgical Rhinoplasty with PDO Threads – TJ Tsay, MD

8:30 - 8:45

8:45 - 9:00

9:00 - 9:15

9:15 - 9:30

9:30 - 10:00

10:00 - 10:30

10:30 - 12:30

10:30 - 10:45

10:45 - 11:00

11:00 - 11:15

11:15 - 11:30

11:30 - 12:30

12:30 - 1:30

1:30 - 4:00

1:30 - 1:45

1:45 - 2:00

2:00 - 2:15

2:15 - 2:30

2:30 - 2:45

2:45 - 4:00

4:00 - 5:00

4:00 - 4:15

4:15 - 4:30

4:30 - 4:45

4:45 - 5:00

Surgical Track - II Posto

Appreciating Your Limitations As A Practitioner Across Patients From Different Ethnic Backgrounds – Priya Chadha, MD

What Non-Surgical Procedures Make Future Surgical Procedures More Complicated/Risky? – Marc Mani, MD

Hemp Seed Oil Unleashed: Cannabidol in Aesthetics – Francine Young, RN

Lower Lid Blepharoplasty: The Growing Case For An Internal Approach – Jeffrey Joseph, MD

PANEL With Live Q&A – Priya Chadha, MD, Jeffrey Joseph, MD, Marc Mani, MD, TJ Tsay, MD, Sherly Soleiman, MD, Francine Young, RN

Break With Exhibitors

SURGERY OF THE NOSE - Preservation & Structural Rhinoplasty Didactics & Debate

Moderator: John Vartanian, MD

Preservation Rhinoplasty WITHOUT Ultrasonic Tools – John Vartanian, MD

Mastering Tip Positioning – Mohsen Naraghi, MD

Modern Approach To Closed Rhinoplasty – John Diaz, MD

Minimally Invasive Procedures To Improve Rhinoplasty Results – David Saadat, MD

DEBATE: Preservation vs Structural Rhinoplasty

Lunch with Exhibitors

Facelifting and Fat Grafting

Moderator: Joseph Niamtu, III, DMD

Endoscopic, Scarless Composite Flap Face and NeckLift – Marc Mani, MD

Preservation Facelift: An Evolution in Deep Plane Face and Neck Lifting – Hadyeh Ziai, MD

My Personal Approach to Deep Plane Face and Neck Lift – Joseph Niamtu, III, DMD

Trim The Fat and Use To Enhance The Face - New Concepts in Fat Grafting – David Samimi, MD

Preservation Deep Plane Facelift With A Twist – Kevin Sadati, DO

Comprehensive Non-Surgical Facial Rejuvenation using RF Microneedling – LIVE DEMONSTRATION – Demetri Arnaoutakis, MD

Prevention and Management of Complications

Moderator: Michael Newman, MD

Combination Peri-Oral Rejuvenation Injectables Plus Heavy Laser Resurfacing – Joel Cohen, MD

Management of Rhinoplasty Over-Resection Complications By Minimally Invasive Non-Rib Graft Surgery – Mohsen Naraghi, MD

Breast and Body Complications – Michael Newman, MD

PANEL – Joel Cohen, MD, Mohsen Naraghi, MD, Michael Newman, MD

www.cosmeticacademymeeting.org

Day 3 - Track 3 Practice Marketing & Business Sessions

Saturday March 23, 2024 Burton Room

7:30 - 8:00

8:00 - 10:00

8:00 - 8:20

8:20 - 8:40

8:40 - 9:00

9:00 - 9:20

9:20 - 9:40

9:40 - 10:.00

10:00 - 10:30

10:30 - 10:50

10:50 - 11:10

11:10 - 11:30

Breakfast with Exhibitors in Main Exhibit Area

THE BUSINESS OF AESTHETICS

Moderator: Josh DeBlasio

Retention and Conversion: What Is It and How Do We Measure? – Julie Davis, JD-MHA

Maximizing Profits Through Emotional Intelligence – Megan Smith

Add A Million Dollar Revenue Stream To Your Aesthetic Practice: Using A Medically Managed Weight Loss Program

– Rachel Fidino, DNP

Creating A Digital Sales Funnel & Building A Sales Plan – Jared Rohrer

Successfully adding a new device or product to your practice: A strategic approach to maximize your ROI – Brian Hayes

Bridging your consultation to retail: You owe it to your patients – Zena Gabriel, MD

Break With Exhibitors

Pricing Strategies for Success: Tips And Tricks To Drive Profitability, Patient Outcomes And Differentiation – Josh DeBlasio

Crafting A Seductive Branding Strategy – Yara Attalla, RPN

Integrative Formula To Eradicate The One-Size Fits-All Approach: When Treating Patients In Your Aesthetic Practice

– Rachel Fidino, DNP

11:30 - 12:30 PRIVATE

EQUITY WORKSHOP

Selling Your Practice to Private Equity - Pros and Cons - The True Experience.

Moderator: Josh DeBlasio

– Sheila Barbarino, MD, Shawna Chrisman, ACNP, Julie Davis, JD-MHA, Rachel Fidino, DNP, Zena Gabriel, MD, Annie Hockey, Amanda Holden, MD, Steven F. Weiner, MD

- 5:30 pm

• Anatomy - identification of structures and how to identify injectables

• Learn how to incorporate ultrasound into your practice

• Learn how to perform ultrasound guided injections

• Discuss treatment of vascular occlusions with ultrasound guidance

www.cosmeticacademymeeting.org

Steven Sorr,

JAW INSPIRING

First and only hyaluronic acid filler approved for jawline definition1,2

Actual patient treated with JUVÉDERM ® VOLUX ® XC in the jawline. Results may vary. To

JUVÉDERM® VOLUX® XC Important Information

INDICATIONS

A defining gel specifically designed for the jawline1

JUVÉDERM® VOLUX® XC injectable gel is indicated for subcutaneous and/or supraperiosteal injection for improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

This product should not be used in patients with severe allergies marked by a history of anaphylaxis or presence of multiple severe allergies, or in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in this product.

WARNINGS

• Do not inject into blood vessels. Introduction of this product into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting the product, for example, after insertion of the needle, and just before injection, the plunger rod can be withdrawn slightly to aspirate and verify the needle is not intravascular, inject the product slowly and apply the least amount of pressure necessary. Rare but serious adverse events associated with the intravascular injection of dermal fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, or unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and possibly evaluation by an appropriate health care professional specialist should an intravascular injection occur

• Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled

PRECAUTIONS

• To minimize the risk of potential complications, this product should only be used by healthcare professionals who are knowledgeable about the anatomy and the product for use in the jawline, and who have appropriate training in facial anatomy, vasculature, safe injection techniques, and identification and management of potential adverse events, including intravascular complications

• The potential risks of soft tissue injections should be discussed with patients prior to treatment to ensure they are aware of signs and symptoms of complications

• The safety and effectiveness for the treatment of anatomic regions other than the jawline have not been established in controlled clinical studies

High patient satisfaction and proven results 1

• The safety for use of JUVÉDERM® VOLUX® XC during pregnancy, in breastfeeding females, and in patients under 22 years has not been established

• The safety for use of JUVÉDERM® VOLUX® XC in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied

• Dermal filler implantation carries a risk of infection. Follow standard precautions

• Dermal fillers should be used with caution in patients on immunosuppressive therapy

• Patients who are using products that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites

• Patients may experience late-onset AEs with use of injectable gel implants, including JUVÉDERM® VOLUX® XC

• Injection of more than 9 mL of JUVÉDERM® VOLUX® XC for improvement of jawline definition has not been studied

• Based on preclinical studies, patients should be limited to 20 mL of any JUVÉDERM® injectable gel per 60 kg (132 lb) body mass per year. The safety of injecting greater amounts has not been established

ADVERSE EVENTS

The most common reported side effects were tenderness, lumps/bumps, pain, swelling and firmness, swelling pain, bruising, redness, itching, and discoloration. The majority of these were mild or moderate and resolved within 14 days. To report an adverse reaction with JUVÉDERM® VOLUX® XC, please call Allergan® Product Support at 1-877-345-5372. Please visit JuvedermDFU.com for more information.

JUVÉDERM® VOLUX® XC is available only by a licensed physician or properly licensed practitioner.

References: 1. JUVÉDERM® VOLUX™ XC Directions for Use, May 2023. 2. FDA approves JUVÉDERM® VOLUX™ XC for improvement of jawline definition. News release. Allergan Aesthetics, an AbbVie company; August 3, 2022. Accessed August 15, 2023. https://news.abbvie.com/news/ press-releases/fda-approves-juvderm-volux-xc-for-improvement-jawline-definition.htm

© 2023 AbbVie. All rights reserved. JUVÉDERM, VOLUX, and their designs are trademarks of Allergan Holdings France SAS, an AbbVie company, or its affiliates. JUV157391-v3 08/23 023526

Day 3 - Track 4 in Palm/Linden Rooms

Saturday March 23, 2024 Palm Room

8:00 - 10:00

10:30 - 12:30

1:30 - 3:00

3:30 - 5:30

MCA MASTERS SERIES WITH LIVE DEMONSTRATION

PALM ROOM

Sculptra Facial and Combined Therapy

- Live Demonstration

Unlock the Future of Aesthetic Mastery: Sculpt, Enhance, Innovate with Sculptra at the Apex of Injectable Excellence

• Embrace a multidisciplinary approach that combines artistry, science, and medical expertise to elevate your aesthetic practice and deliver personalized treatment solutions.

How To Integrate Anti-Aging & Longevity Into My Practice

Hormones & Wellness/Longevity/Sexual Wellness/Weight Loss

Hormonal Optimization of

• Thyroid • Progesterone

• Estrogen • Testosterone

Longevity updates:

• Genetic Testing

Impact of the Gut-Skin Axis Mitochondrial Effect On Skin

• Nutritional Systems for Different Genetic Profiles

• How To Market/Educate Personalized Health & Wellness Products Based on Unique DNA

Non-Surgical Rhinoplasty

• Fundamentals and Anatomy of Non-Surgical Rhinoplasty (NSR)

• Identifying Candidates for NSR

• Product Selection in NSR

• Preventing Complications in NSR

• Management of Complications in NSR

• Techniques with LIVE DEMONSTRATION of NSR

Combined Therapy Radiesse, Renuva & Sculptra with LIVE DEMONSTRATIONS - Face

• Review Specific Reconstitutions of Renuva, Radiesse, and Sculptra

• Demonstrate Techniques of Using Biostimulators (Renuva, Radiesse, Sculptra)

• Discuss Specific Techniques and Tips to Maximize Patient Safety and Results

• Review of Complication Prevention and Management

MCA Masters Workshops are additional fee of $950 each attendee and non-CME

www.cosmeticacademymeeting.org

Dr. Giulio Giammarioli

Anusha Dahanyake, NP

Amy Lynn, RN

Natasha Cook, MD

Steven Sorr, NMD

Priya Chadha, MD

Natalia Guzman, FNP

Joelle Lieman, MD

Dr. Sara Mahdavi, PhD

Shino Bay Aguilera, DO

Francine Young, RN

VISIT THE GALDERMA BOOTH TO LEARN MORE

HIT™ is a patient-centric and science-based approach leveraging injectors’ expertise and Galderma’s Aesthetic Collection to create an Individualized Treatment Plan. Kiss and Smile is a treatment plan that improves firmness in the cheeks (Sculptra), volumizes and defines lips (Restylane® Kysse), and smooths lines around the mouth (Restylane® Defyne/Restylane® Refyne) for natural-looking results.1-4

REFERENCES: 1. Sculptra. Instructions for Use. Galderma Laboratories, L.P., 2023. 2. Restylane Kysse. Instructions for Use. Galderma Laboratories, L.P., 2023. 3. Restylane Refyne

Instructions for Use. Galderma Laboratories, L.P., 2023. 4. Restylane Defyne. Instructions for Use. Galderma Laboratories, L.P., 2023.

SCULPTRA® IMPORTANT SAFETY INFORMATION

Indication: Sculptra® (injectable poly-L-lactic acid (PLLA-SCA)) is indicated for use in people with healthy immune systems for the correction of shallow to deep nasolabial fold contour deficiencies, fine lines and wrinkles in the cheek region, and other facial wrinkles.

Sculptra should not be used by people that are allergic to any ingredient of the product or have a history of keloid formation or hypertrophic scarring. Safety has not been established in patients who are pregnant, lactating, breastfeeding, or under 18 years of age.

Sculptra has unique injection requirements and should only be used by a trained healthcare practitioner. Contour deficiencies should not be overcorrected because they are expected to gradually improve after treatment.

Sculptra should not be injected into the blood vessels as it may cause vascular occlusion, infarction or embolic phenomena. Use at the site of skin sores, cysts, pimples, rashes, hives or infection should be postponed until healing is complete. Sculptra should not be injected into the red area (vermillion) of the lip or in the periorbital area.

The most common side effects after initial treatment include injection site swelling, tenderness, redness, pain, bruising, bleeding, itching and lumps. Other side effects may include small lumps under the skin that are sometimes noticeable when pressing on the treated area. Larger lumps, some with delayed onset with or without inflammation or skin discoloration, have also been reported.

Sculptra is available only through a licensed practitioner. Complete Instructions for Use are available at www.SculptraUSA.com/IFU.

RESTYLANE FAMILY IMPORTANT SAFETY INFORMATION

The Restylane family of products are indicated for patients over the age of 21, and includes Restylane®, Restylane-L®, Restylane® Lyft with Lidocaine, Restylane® Silk, Restylane® Kysse Restylane® Refyne Restylane® Defyne Restylane® Contour, and Restylane® Eyelight

APPROVED USES

Restylane® and Restylane-L® are for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane® and Restylane-L® are also indicated for injection into the lips.

Restylane® Lyft with Lidocaine is for deep implantation into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and for cheek augmentation and for the correction of age-related midface contour deficiencies. Restylane® Lyft with Lidocaine is also indicated for injection into the dorsal hand to correct volume loss.

Restylane® Silk is for lip augmentation and for correction of perioral wrinkles.

Restylane® Kysse is for lip augmentation and for correction of upper perioral wrinkles.

Restylane® Refyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.

Restylane® Defyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe deep facial wrinkles and folds, such as nasolabial folds.

Restylane® Defyne is also indicated for injection into the mid-to deep dermis (subcutaneous and/or supraperiosteal) for augmentation of the chin region to improve the chin profile in patients with mild to moderate chin retrusion.

Restylane® Contour is for cheek augmentation and for the correction of midface contour deficiencies.

Restylane® Eyelight is for the improvement of infraorbital hollowing.

Do not use if you have severe allergies with a history of severe reactions (anaphylaxis), are allergic to lidocaine or gram-positive bacterial proteins used to make hyaluronic acid, prone to bleeding, or have a bleeding disorder. The safety of use while pregnant or breastfeeding has not been studied. Tell your doctor if you have a history of scarring or pigmentation disorders as these side effects can occur with hyaluronic acid fillers.

Tell your doctor if you are planning other cosmetic treatments (i.e., lasers and chemical peels) as there is a possible risk of inflammation at the injection site.

Tell your doctor if you’re taking medications that lower your body’s immune response or affect bleeding, such as aspirin or warfarin, as these medications may increase the risk of bruising or bleeding at the gel injection site. Using these products on gel injection sites with skin sores, pimples, rashes, hives, cysts, or infections should be postponed until healing is complete.

The most common side effects are swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. Delayed-onset inflammation near the site of dermal filler injections is one of the known adverse events associated with dermal fillers, and cases have been reported to occur at the dermal filler treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to treatment or resolved on its own. Serious but rare side effects include delayed onset infections, recurrence of herpetic eruptions, and superficial necrosis at the injection site. The risk of unintentional injection into a blood vessel is small but can occur and could result in serious complications, which may be permanent including, vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection.

To report a side effect with any Restylane® product, please call Galderma Laboratories, L.P at 1-855-425-8722.

To learn more about serious but rare side effects and full Important Safety Information, visit www.RestylaneUSA.com.

©2024 Galderma Laboratories, L.P.

All trademarks are the property of their respective owners. US-SCA-2400015

Actual

Day 3 - Track 4 in Palm/Linden Rooms

Saturday March 23, 2024 Linden Room

MCA MASTERS SERIES WITH LIVE DEMONSTRATION

LINDEN ROOM

7:30 - 9:30

Lip/Perioral/Jawline Masters Workshop

Take Your Lip Filler Results to the Next Level:

Live Demonstration

• 3 Most Popular Lip Techniques

• Optimal Lip Proportions & Volumes

• Dental Blocks & Analgesia

• Advanced Cannula Techniques for Perioral & Marionette

• New Technique for Treating Perioral Vascular Occlusions

10:00 - 12:00

PDO Threads. A 360 Degree Overview and Approach in the Use of Threads For Facial Rejuvenation and Lifting with Live Demonstration

• Identify Good Candidates for PDO Threadlifts

• Vector Design

• Numbing Protocols

• Threads Techniques - Reverse Vector to Deep Temporal Fascia, Signature Vertical, Jawline

• Nose Threads

1:30 - 3:00

3.30 to 5:30

Sculptra/Radiesse/Renuva Body/ Booty Workshop

Live Demonstration

• Mechanism of Action of the Hottest Regenerative Medicine Dermal Fillers

• Body Contouring with Biostimulators (Renuva, Radiesse, Sculptra)

• Reconstitutions and Injectable Techniques for CAHA Hyperdiluted, Adipose Matrix Allograft Filler (Renuva) and PLLA (Sculptra)

• Review Complication Prevention and Management

Full Face Balancing Workshop

Live Demonstration

• Botox Cosmetic to Upper Third, Lower Third, and Jawline/Neck/Platysma

• Panfacial Injections – Voluma Cheeks / Chin, Volbella to Tear Trough, Vollure Perioral, and Volux to Jawline

• Skin Boosting with SkinVive – Best Techniques for Face and Neck

MCA Masters Workshops are additional fee of $950 each attendee and non-CME

www.cosmeticacademymeeting.org

Shanna Concepcion, RN

Sherly Soleiman, MD

Amy Lynn, RN

Sheila Barbarino, MD

Natalia Guzman, FNP

Francine Young, RN

Lisa Espinoza, MD

Kian Karimi, MD

Amy Faircloth, RN

DiamondGlow® is the proven hydradermabrasion treatment that harnesses 3X1™ technology to deeply clean and rejuvenate the skin, delivering an instant glow with lasting results. It works exclusively with clinically proven SkinMedica® Pro-Infusion Serums to promote skin health.

And now, we’re excited to introduce SkinMedica® Even & Correct Advanced Brightening Pro-Infusion Serum A professional skin brightening treatment, this powerful serum helps correct the appearance of uneven tone, hyperpigmentation, and dark spots.

6 TREATMENTS (WEEK 12)

Reference: 1. Data on file at SkinMedica®.

DiamondGlow ® Indication and Use

The DiamondGlow® device is indicated for general dermabrasion of the skin and also delivers topical cosmetic serums onto the skin.

DiamondGlow ® Important Safety Information

DiamondGlow® is contraindicated in patients who have compromised skin quality including but not limited to, sunburned, chapped, irritated or broken skin, open wounds, active, weeping acne, cold sores, or herpetic ulcers. Ask your patient if they are pregnant or lactating or if they have any medical conditions, including allergies, and usage of topical medication on the area to be treated.

Typical side effects include a scratchy, stinging sensation during the treatment and temporary tightness, redness or slight swelling after the treatment. Rare serious side effects may also occur and include severe skin irritation and allergic reactions. Cease use of the device immediately if any of these serious side effects are observed.

Patients should be advised to use a sunscreen with a sun protection factor of 30 or higher following treatment.

Consult the DiamondGlow® User Manual for a complete list of Contraindications, Warnings, Precautions, and potential side effects.

SkinMedica ® Pro-Infusion Serums Disclaimer

SkinMedica® Pro-Infusion Serums are intended to meet the FDA’s definition of a cosmetic product, an article applied to the human body to cleanse, beautify, promote attractiveness, and alter appearances. These products are not intended to be drugs

FDA and the statements have not been evaluated by the FDA.

Day 4 - Track 1 in Main Ballroom

Sunday March 24, 2024 Main Ballroom

MCA CADAVER WORKSHOP

7:15 am Breakfast with Exhibitors

Course Director: Kian Karimi, MD

MCA CADAVER WORKSHOP

Advanced Fillers, Injectables, PDO Threads & Ultrasound Guided Injection Hands-ON Cadaver Dissection

Course – Kian Karimi, MD, Jonathan Sykes, MD, Amy Lynn, RN, Steven Sorr, NMD

8 am - 1: 30 pm Hands-On Learning Experience

• Pertinent Anatomy for the Injector and Identifying Danger Areas

• Neuromodulator Techniques

• Periocular (Tear Trough, Temple) Anatomy and Injection Techniques – Needle and Cannula

• Anatomy of Midface Fat Compartments and Filler Injection Technique Needle and Cannula

• PDO Threads Techniques (Mesh and Lifting Techniques)

• Surgical Faculty at Each Station to Guide Attendees Through Hands-ON Injections

• Fillers and Threads Will Be Provided

• Lip Injection Techniques

• Ultrasound Guided Injection

www.cosmeticacademymeeting.org

LA-MCA Cadaver Course workshop is not included in registration fee and is $2950 each per attendee

Day 4 - Track 4 Palm/Linden Rooms

MCA MASTERS WORKSHOPS WITH LIVE DEMONSTRATION

LINDEN ROOM

8:30 - 10:00

Mastering Peri-Orbital Injections

Treating The Infraorbital and Midface Areas With Dermal Fillers:

• Danger Zones

• Injection Pearls & Pitfalls

• Needle & Micro-Cannula Techniques

• How to Maximize Aesthetic Outcomes via Artistry

10:30 - 12:30

Facial Neuromodulator Techniques:

• Glabella, Forehead, Crows

• Nose / Gummy Smile / Lip Lines / Lip Flip

• Chin / Jawline / Lower Mouth Depressors (Platysma, DAO, Mentalis)

• Facial Slimming and Headache Therapy (Temporalis, Masseter, Migraine, Trapezius)

• Novel Uses of Toxin - Pores, Acne, Rosacea, Sweating, Skin Quality

MCA Masters Workshop are additional fee of $950 each per attendee and non-CME

John Vartanian, MD Sandy Zhang-Nunes, MD

Julie Bass Kaplan, FNP

Julie Woodward, MD Video Presentation

Laurence Rifkin, DDS Sharon Stewart, PAC

Not an actual patient.

IMPORTANT INFORMATION ABOUT

Dysport® (DIS-port) (abobotulinumtoxinA) for Injection

BRIEF SUMMARY

This summary contains important information about Dysport (DIS-port) for injection. Read this information carefully before using Dysport. Ask your doctor if you do not understand any of this information or if you want to know more about Dysport

For full Prescribing Information and Medication Guide, please see the package insert.

What is Dysport?

Dysport is a prescription injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age.

Important Safety Information

WARNING: DISTANT SPREAD OF TOXIN EFFECT

In some cases, the effects of Dysport and all botulinum toxin products may affect areas of the body away from the injection site. Symptoms can happen hours to weeks after injection and may include swallowing and breathing problems, loss of strength and muscle weakness all over the body, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, or loss of bladder control. Swallowing and breathing problems can be life threatening and there have been reports of death. You are at the highest risk if these problems are pre-existing before injection. These effects could make it unsafe for you to drive a car, operate machinery, or do other dangerous activities.

Who should not take Dysport?

Do not take Dysport if you:

• are allergic to Dysport or any of its ingredients. See the end of this Medication Guide for a list of ingredients in Dysport are allergic to cow’s milk protein had an allergic reaction to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB), Botox® (onabotulinumtoxinA), or Xeomin® (incobotulinumtoxinA)

• have a skin infection at the planned injection site

• Under 18 years of age

• Pregnant or breastfeeding

What additional warnings and precautions should I know about Dysport?

• The dose of Dysport is not the same as the dose of any other botulinum toxin product and cannot be compared to the dose of any other botulinum toxin product you may have used.

• Dysport may not be right for you if you have surgical changes to your face, very weak muscles in the treatment area, your face looks very different from side to side, the injection site is inflamed, you have droopy eyelids or sagging eyelid folds, deep facial scars, thick oily skin, or if your wrinkles can’t be smoothed by spreading them apart.

• Tell your doctor about all of your medical conditions, especially if you have a disease that affects muscles and nerves (such as amyotrophic lateral sclerosis [ALS or Lou Gehrig’s disease], myasthenia gravis, or Lambert-Eaton syndrome), allergies to any botulinum toxin product or had any side effect from any botulinum toxin product in the past, a breathing problem (such as asthma or emphysema), swallowing problems, bleeding problems, diabetes, or a slow heart beat or other problem with your heart rate or rhythm, plans to have surgery, had surgery on your face, have weakness in or near your muscles being treated, drooping eyelids, any other change in the way your face normally looks, or are pregnant or breastfeeding or planning to become pregnant or breastfeed Patients with swallowing or breathing difficulties or a disease that affects muscles and nerves may have a higher risk of serious side effects, including severe swallowing and breathing problems, after treatment with Dysport

• Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins and herbal and other natural products. Using Dysport with

certain other medicines may cause serious side effects. Do not start any new medicines while taking Dysport without talking to your doctor first.

• Especially tell your doctor if you: have received any other botulinum toxin product, such as Myobloc® (rimabotulinumtoxinB), Botox® (onabotulinumtoxinA), or Xeomin® (incobotulinumtoxinA), in the last four months or any in the past (be sure your doctor knows exactly which product you received, have recently received an antibiotic by injection, take muscle relaxants, take an allergy or cold medicine, or take a sleep medicine.

What are the side effects of Dysport?

The most common side effects of Dysport include nose and throat irritation, injection site pain, upper respiratory infection, blood in urine, headache, injection site reaction, eyelid swelling, eyelid drooping, sinus infection, and nausea.

These are not all the possible side effects of Dysport. Call your doctor for medical advice about side effects.

You may report side effects to FDA at www.fda.gov/medwatch or 1-800-FDA-1088.

This Brief Summary summarizes the most important information about Dysport. If you would like more information, talk with your doctor.

What are the ingredients of Dysport?

Active ingredient: (botulinum toxin Type A)

Inactive ingredients: human albumin and lactose. Dysport may contain cow’s milk protein.

Where should I go for more information about Dysport?

• Talk to your doctor.

• Visit www.DYSPORTUSA.com.

GALDERMA LABORATORIES, L.P.

Dallas, Texas 75201 USA

Revised: September 2023

RESTYLANE FAMILY IMPORTANT SAFETY INFORMATION

The Restylane family of products are indicated for patients over the age of 21, and includes Restylane®, Restylane-L®, Restylane® Lyft with Lidocaine Restylane® Silk Restylane® Kysse Restylane® Refyne Restylane® Defyne Restylane® Contour, and Restylane® Eyelight

APPROVED USES

Restylane® and Restylane-L® are for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane® and Restylane-L® are also indicated for injection into the lips.

Restylane® Lyft with Lidocaine is for deep implantation into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and for cheek augmentation and for the correction of age-related midface contour deficiencies. Restylane® Lyft with Lidocaine is also indicated for injection into the dorsal hand to correct volume loss.

Restylane® Silk is for lip augmentation and for correction of perioral wrinkles.

Restylane® Kysse is for lip augmentation and for correction of upper perioral wrinkles.

Restylane® Refyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.

Restylane® Defyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe deep facial wrinkles and folds, such as nasolabial folds. Restylane® Defyne is also indicated for injection into the mid-to deep dermis (subcutaneous and/or supraperiosteal) for augmentation of the chin region to improve the chin profile in patients with mild to moderate chin retrusion.

Restylane® Contour is for cheek augmentation and for the correction of midface contour deficiencies.

Restylane® Eyelight is for the improvement of infraorbital hollowing.

Do not use if you have severe allergies with a history of severe reactions (anaphylaxis), are allergic to lidocaine or grampositive bacterial proteins used to make hyaluronic acid, prone to bleeding, or have a bleeding disorder. The safety of use while pregnant or breastfeeding has not been studied. Tell your doctor if you have a history of scarring or pigmentation disorders as these side effects can occur with hyaluronic acid fillers. Tell your doctor if you are planning other cosmetic treatments (i.e., lasers and chemical peels) as there is a possible risk of inflammation at the injection site.

Tell your doctor if you’re taking medications that lower your body’s immune response or affect bleeding, such as aspirin or warfarin, as these medications may increase the risk of bruising or bleeding at the gel injection site. Using these products on gel injection sites with skin sores, pimples, rashes, hives, cysts, or infections should be postponed until healing is complete.

The most common side effects are swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. Delayed-onset inflammation near the site of dermal filler injections is one of the known adverse events associated with dermal fillers, and cases have been reported to occur at the dermal filler treatment site following viral or bacterial illnesses or infections, vaccinations, or dental procedures. Typically, the reported inflammation was responsive to treatment or resolved on its own. Serious but rare side effects include delayed onset infections, recurrence of herpetic eruptions, and superficial necrosis at the injection site. The risk of unintentional injection into a blood vessel is small but can occur and could result in serious complications, which may be permanent including, vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. As with all skin injection procedures, there is a risk of infection.

To report a side effect with any Restylane® product, please call Galderma Laboratories, L.P at 1-855-425-8722.

To learn more about serious but rare side effects and full Important Safety Information, visit www.RestylaneUSA.com.

SCULPTRA® IMPORTANT SAFETY INFORMATION

Indication: Sculptra® (injectable poly-L-lactic acid (PLLA-SCA)) is indicated for use in people with healthy immune systems for the correction of shallow to deep nasolabial fold contour deficiencies, fine lines and wrinkles in the cheek region, and other facial wrinkles.

Sculptra should not be used by people that are allergic to any ingredient of the product or have a history of keloid formation or hypertrophic scarring. Safety has not been established in patients who are pregnant, lactating, breastfeeding, or under 18 years of age.

Sculptra has unique injection requirements and should only be used by a trained healthcare practitioner. Contour deficiencies should not be overcorrected because they are expected to gradually improve after treatment.

Sculptra should not be injected into the blood vessels as it may cause vascular occlusion, infarction or embolic phenomena. Use at the site of skin sores, cysts, pimples, rashes, hives or infection should be postponed until healing is complete.

Sculptra should not be injected into the red area (vermillion) of the lip or in the peri-orbital area.

The most common side effects after initial treatment include injection site swelling, tenderness, redness, pain, bruising, bleeding, itching and lumps. Other side effects may include small lumps under the skin that are sometimes noticeable when pressing on the treated area. Larger lumps, some with delayed onset with or without inflammation or skin discoloration, have also been reported.

Sculptra is available only through a licensed practitioner. Complete Instructions for Use are available at www.SculptraUSA.com/IFU.

©2024 Galderma Laboratories, L.P.

The Dysport trademark is used under license.

US-DYS-2400021

CO2LIFT CARBOXY GEL

The Fastest Way to Better Skin

IN A RECENT CLINICAL TRIAL, AFTER 6 TREATMENTS

39% Luminosity

42% Radiance

30% Sagging

27% Pigmentation

24% Fine Lines

20% Wrinkles

26% Elasticity at W4

28% at W10

FACE. BODY. VAGINA.

@CO2LIFT • LUMISQUE.COM

Recommended by Phaedra

O u r E l e c t r o S o n i c R e s o n a n c e ™ T r e a t m e n t s

C o m b a t t h e A g i n g P r o c e s s a n d F a t C e l l s

b y U s i n g N o n - F o c u s e d U l t r a s o u n d

T e c h n o l o g y T h a t i s B o t h R e j u v e n a t i n g a n d N o n - I n v a s i v e

e h a v e m o r e y o u t h f u l l y , w i t h o u t n g n o n - f o c u s e d u l t r a s o u n d w a v e e c t r o s t i m u l a t i o n f i e l d

as featured on ...

SEMINAR

Saturday, April 27, 2024

9 am - 12 noon Virtual Seminar

Join Angela O’Mara, President of TPI Media Group, Inc. and other aesthetic innovators and influencers for a morning of inspiration and great learning. If you want to take your aesthetic practice to new heights, want to be seen as a recognized brand, or aspire to be a KOL or leader within the medical aesthetics industry, this seminar is for you.

REGISTER HERE!

Angela O’Mara President TPI Media Group,

Inc.

Podcast

Host: The Aesthetic Insider PR & Marketing Consultant

“Grab your coffee and joins us for an event that could put you on the path to taking your aesthetic journey to the next level”.

Introducing Tixel® by Sentient!

Giles